Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 1

In this webcast from the 'Looking to the Future With Hope: Advances in the Treatment of AML' symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Gail J. Roboz discusses novel therapies for the treatment of newly diagnosed acute myeloid leukemia (AML).

© 2019 Imedex, an HMP Company

[sabboonaagirma]

It is such an amazing lecture..God bless you 🙏

[martinezbiz]

My wife and I lost our just turned 2 year old son 7 months ago to Aml. He had MLL gene rearrangement or subtype KMT2A or 11q23. He had a translocation between chromosomes 6 and 11, t(6;11). He received cytarabine, daunorubicin, etoposide, gemtuzumab ozagamicin then mitoxNtrone and cytarabine. He relapsed after the second chemo which signified refractory Aml which had a poor prognosis. Decitabine with mylotarg was then used. He died shortly after from within 4 months of treatment. Some side effects he had were bloody nausea and diahrea. Horrible bloody mouth sores. He was in pain all over. His right eye was covered by a leukemia pool that ended up bleeding.He had a lot of liquid in his lungs which they thought was pnemonia. He ultimately died from a brain bleed within 24 hours caused we think by the chemo.

[kellypearson]

Thank you for the update. I have Acute Myeloid Leukemia